Infinite Evolution · AI-Native Biotech
We are building the computational foundation for the next era of biology — transforming living cells into programmable, verifiable, and perpetually evolving systems.
Explore Our MissionWho We Are
INFevo is an AI-native biotechnology company built on the conviction that life is computable. We do not merely apply AI to data; we architect the fundamental intelligence of discovery.
Our mission is to construct the most sophisticated Virtual Cell model ever conceived. By digitizing the fundamental unit of life, we use the individual cell as a high-fidelity sensor—a window to observe, simulate, and predict the emergent complexity of clinical outcomes. Through the seamless integration of generative inference and automated validation, we de-risk the most challenging biological frontiers, from the mysteries of neurodegeneration to the systemic decline of aging.
At INFevo, we are not just building a platform; we are building the infrastructure of intent, ensuring that the medicines of tomorrow are no longer captured by chance, but realized by design.
Our Approach
A generative foundation model trained on massive multi-omic scales. It decodes the universal syntax of life across species and states, transforming biological complexity into predictable insights.
A multidimensional knowledge architecture that transcends static databases. It connects molecules, pathways, phenotypes, and clinical outcomes — growing smarter with every experiment.
A seamless transition from in-silico prediction to automated in-vitro validation. We don’t just predict biology; we verify it, creating a self-reinforcing flywheel that transforms complexity into accelerated discovery.
"洞见未知，愈见新生。
Seen the unseen, heal the untreated."
INFevo · Core Vision
The Team
Our team unites researchers and entrepreneurs from the world's leading academic institutions and companies — people who have spent careers at the intersection of biology, artificial intelligence, mathematics, and drug discovery.
We are selectively engaging with investors and partners who share our conviction that the deepest understanding of life will yield the most profound advances in medicine.